Bicara Therapeutics Inc [BCAX] stock prices are up 1.97% to $19.12 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BCAX shares have gain 1.93% over the last week, with a monthly amount glided 2.27%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Bicara Therapeutics Inc [NASDAQ: BCAX] stock has seen the most recent analyst activity on December 06, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $42. Previously, Rodman & Renshaw started tracking the stock with Buy rating on November 05, 2024, and set its price target to $48. On October 08, 2024, TD Cowen initiated with a Buy rating. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $47 on October 08, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $35 as its price target on October 08, 2024.
The stock price of Bicara Therapeutics Inc [BCAX] has been fluctuating between $16.01 and $28.09 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Bicara Therapeutics Inc [NASDAQ: BCAX] shares were valued at $19.12 at the most recent close of the market. An investor can expect a potential return of 83.05% based on the average BCAX price forecast.
Analyzing the BCAX fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.37 points at the first support level, and at 17.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.49, and for the 2nd resistance point, it is at 19.87.
Ratios To Look Out For
It’s worth pointing out that Bicara Therapeutics Inc [NASDAQ:BCAX]’s Current Ratio is 36.01. In addition, the Quick Ratio stands at 36.01.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Sep 16 ’24 when 1.83 million shares were purchased. Possible Members of 10% Group, Flynn James E completed a deal on Sep 17 ’24 to buy 70000.0 shares.
